Maureen F. Maughan

1.0k total citations
17 papers, 840 citations indexed

About

Maureen F. Maughan is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Maureen F. Maughan has authored 17 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Immunology and 5 papers in Virology. Recurrent topics in Maureen F. Maughan's work include Herpesvirus Infections and Treatments (7 papers), Immunotherapy and Immune Responses (7 papers) and HIV Research and Treatment (5 papers). Maureen F. Maughan is often cited by papers focused on Herpesvirus Infections and Treatments (7 papers), Immunotherapy and Immune Responses (7 papers) and HIV Research and Treatment (5 papers). Maureen F. Maughan collaborates with scholars based in United States, South Africa and Russia. Maureen F. Maughan's co-authors include Robert A. Olmsted, Elizabeth A. Reap, J. Glenn Morris, Xiaoyan Wang, Lawrence B. Lachman, Jeffrey D. Chulay, Janice E. Clements, Zhaohao Liao, James E. K. Hildreth and Pamela K. Norberg and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Maureen F. Maughan

16 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maureen F. Maughan United States	12	360	314	268	253	226	17	840
Frédéric Delebecque France	13	532 1.5×	235 0.7×	315 1.2×	430 1.7×	307 1.4×	16	1.1k
Te-Hui Chou United States	15	331 0.9×	221 0.7×	310 1.2×	244 1.0×	311 1.4×	18	782
Minoru Kidokoro Japan	15	419 1.2×	319 1.0×	239 0.9×	273 1.1×	175 0.8×	33	966
Autumn Ruiz United States	13	221 0.6×	259 0.8×	229 0.9×	278 1.1×	442 2.0×	20	818
Franck Lemiale United States	12	211 0.6×	217 0.7×	395 1.5×	152 0.6×	211 0.9×	19	863
Vincent P. Smith United Kingdom	11	340 0.9×	188 0.6×	220 0.8×	467 1.8×	239 1.1×	12	882
Giada Mattiuzzo United Kingdom	18	133 0.4×	399 1.3×	208 0.8×	232 0.9×	230 1.0×	48	841
Robert J. Natuk United States	16	329 0.9×	265 0.8×	180 0.7×	488 1.9×	246 1.1×	28	939
Gustaf Ahlén Sweden	18	280 0.8×	248 0.8×	237 0.9×	342 1.4×	81 0.4×	38	1.0k
Michael H. Newberg United States	16	509 1.4×	184 0.6×	253 0.9×	207 0.8×	307 1.4×	16	860

Countries citing papers authored by Maureen F. Maughan

Since Specialization

Citations

This map shows the geographic impact of Maureen F. Maughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen F. Maughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen F. Maughan more than expected).

Fields of papers citing papers by Maureen F. Maughan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen F. Maughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen F. Maughan. The network helps show where Maureen F. Maughan may publish in the future.

Co-authorship network of co-authors of Maureen F. Maughan

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen F. Maughan. A scholar is included among the top collaborators of Maureen F. Maughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen F. Maughan. Maureen F. Maughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Scherm, Michael J., et al.. (2025). Assessment of critical bioprocess parameters for broadly cross-reactive chimeric hemagglutinin influenza virus vaccines. Vaccine. 64. 127671–127671.

Lusk, Jay B., Jesse D. Troy, Peter G. Kranz, et al.. (2022). An Exploratory Analysis of Biomarkers of Perihematomal Edema in the CN-105 in Participants with Acute Supratentorial Intracerebral Hemorrhage (CATCH) Trial. Journal of Stroke and Cerebrovascular Diseases. 31(8). 106600–106600. 3 indexed citations

Avogadri, Francesca, Roberta Zappasodi, Arvin Yang, et al.. (2014). Combination of Alphavirus Replicon Particle–Based Vaccination with Immunomodulatory Antibodies: Therapeutic Activity in the B16 Melanoma Mouse Model and Immune Correlates. Cancer Immunology Research. 2(5). 448–458. 36 indexed citations

Avogadri, Francesca, Taha Merghoub, Maureen F. Maughan, et al.. (2010). Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity. PLoS ONE. 5(9). e12670–e12670. 53 indexed citations

Bernstein, David I., Elizabeth A. Reap, Kaitlin M. Smith, et al.. (2009). Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine. 28(2). 484–493. 156 indexed citations

Hubby, Bolyn, Todd Talarico, Maureen F. Maughan, et al.. (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine. 25(48). 8180–8189. 59 indexed citations

Reap, Elizabeth A., J. Glenn Morris, Sergey A. Dryga, et al.. (2007). Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus. Vaccine. 25(42). 7441–7449. 42 indexed citations

Durso, Robert J., Sofija Andjelić, Jason P. Gardner, et al.. (2007). A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses. Clinical Cancer Research. 13(13). 3999–4008. 56 indexed citations

Talarico, Todd, et al.. (2006). Development and Manufacture of Alphavaccines. BioProcessing Journal. 5(3). 8–14. 4 indexed citations

10.

Goldberg, S., Shirley Bartido, Jason P. Gardner, et al.. (2005). Comparison of Two Cancer Vaccines Targeting Tyrosinase: Plasmid DNA and Recombinant Alphavirus Replicon Particles. Clinical Cancer Research. 11(22). 8114–8121. 48 indexed citations

11.

Gardner, Jason P., Robert J. Durso, Maureen F. Maughan, et al.. (2005). Novel prime-boost combinations of PSMA-based vaccines for prostate cancer. Journal of Clinical Oncology. 23(16_suppl). 2572–2572. 2 indexed citations

12.

Eralp, Yeşim, Xiaoyan Wang, Jianping Wang, et al.. (2004). Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neuin a murine mammary carcinoma model. Breast Cancer Research. 6(4). R275–83. 80 indexed citations

13.

Wang, Xiaoyan, Jian‐Ping Wang, Maureen F. Maughan, & Lawrence B. Lachman. (2004). Alphavirus replicon particles containing the gene for HER2/neuinhibit breast cancer growth and tumorigenesis. Breast Cancer Research. 7(1). R145–55. 35 indexed citations

14.

Williamson, Carolyn, Lynn Morris, Maureen F. Maughan, et al.. (2003). Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development. AIDS Research and Human Retroviruses. 19(2). 133–144. 104 indexed citations

15.

Davis, Nancy, Ande West, Elizabeth A. Reap, et al.. (2002). Alphavirus Replicon Particles as Candidate HIV Vaccines. IUBMB Life. 53(4-5). 209–211. 71 indexed citations

16.

Barber, Sheila A., et al.. (2000). Two Amino Acid Substitutions in the SIV Nef Protein Mediate Associations with Distinct Cellular Kinases. Virology. 276(2). 329–338. 4 indexed citations

17.

Maughan, Maureen F., et al.. (2000). LuSIV Cells: A Reporter Cell Line for the Detection and Quantitation of a Single Cycle of HIV and SIV Replication. Virology. 273(2). 307–315. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact